🧬 Emerging data show GATA2 variants don’t fully lose function—instead, they retain selective enhancer activity, skew hematopoietic differentiation, and may activate inflammatory pathways that contribute to leukemogenesis.
Read more ➡️ www.onclive.com/view/gata2-g...
#Leukemia #MDS #oncology